Dacarbazine Clinical Trials
15 recruitingDrug
Phase 37Phase 27Not Applicable1Phase 41
Showing 1–15 of 15 trials
Recruiting
Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
National Cancer Institute (NCI)1,875 enrolled400 locationsNCT05675410
Recruiting
Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Hodgkin Lymphoma
University College, London1,042 enrolled70 locationsNCT04685616
Recruiting
Phase 2Phase 3
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
TreatmentSurvivalClassical Hodgkin Lymphoma+6 more
Children's Cancer Group, China96 enrolled1 locationNCT06563245
Recruiting
Phase 3
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma
Melanoma, Cutaneous Malignant
Immatics US, Inc.360 enrolled52 locationsNCT06743126
Recruiting
Phase 2
Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma
Classic Hodgkin LymphomaAdvanced Hodgkin LymphomaLugano Classification Stage III Hodgkin Lymphoma AJCC v8+1 more
University of Washington125 enrolled5 locationsNCT06745076
Recruiting
Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
LeiomyosarcomaSynovial SarcomaAlveolar Soft Part Sarcoma
Advenchen Laboratories, LLC325 enrolled24 locationsNCT03016819
Recruiting
Phase 4
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
Hodgkin Lymphoma
Takeda124 enrolled11 locationsNCT06831370
Recruiting
Phase 2
Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk Extremity and Trunk Soft Tissue Sarcoma (TNT-HYPE)
Sarcoma,Soft Tissue
Swiss Cancer Institute24 enrolled8 locationsNCT06835049
Recruiting
Phase 2
Nivo40-AVD for Advanced Classic Hodgkin Lymphoma
Hodgkin Lymphoma, Adult
National Medical Research Radiological Centre of the Ministry of Health of Russia54 enrolled1 locationNCT06984146
Recruiting
Phase 2
BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma
Hodgkin LymphomaAdvanced Hodgkin Lymphoma
University of Miami48 enrolled1 locationNCT07002216
Recruiting
Phase 3
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035
Recruiting
Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center71 enrolled8 locationsNCT06377566
Recruiting
Phase 3
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
Hodgkin Lymphoma, Adult
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia300 enrolled2 locationsNCT04638790
Recruiting
Phase 2
Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Classical Hodgkin Lymphoma
University of Virginia44 enrolled3 locationsNCT05404945
Recruiting
Not Applicable
Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
Classical Hodgkins Lymphoma in Children and Adolescents.
GALIA AVRAHAMI2,200 enrolled1 locationNCT02797717